Abiomed Inc.

This early study is testing a small, temporary heart pump called the Impella BTR in 10 adults with severe, worsening heart failure. The pump is surgically placed to help the heart pump blood while patients recover or wait for their next treatment. Researchers want to see if the d…

This study is testing the safety of a small, temporary heart pump called the Impella ECP. The pump helps support the heart during high-risk procedures to clear blocked arteries. Researchers are tracking serious complications and recovery in 856 patients for 30 days after their pr…

This study is testing the safety of a new, very small heart pump called the Impella ECP. It is designed to help support a patient's blood pressure and heart function during a high-risk procedure to open blocked heart arteries. The research involves 100 adults who need this type o…

This study is collecting real-world data on the safety and effectiveness of a temporary heart pump called the Impella 5.5. It is used to support patients with severely weakened heart function who are undergoing major heart surgery. The goal is to see if the pump helps prevent hea…

This study is testing if using a small heart pump device during a high-risk artery-opening procedure is better than the standard approach for patients with weak heart function. It aims to see if the pump helps reduce serious heart problems like heart attacks, strokes, or death ov…

This study is testing if using a small heart pump called the Impella CP for 30 minutes before the standard artery-opening procedure can reduce permanent damage to the heart muscle during a severe type of heart attack. It compares this new approach to the current standard of care.…

This study aims to collect real-time data from heart pumps (Impella devices) used in patients with cardiogenic shock, a life-threatening condition where the heart suddenly can't pump enough blood. Researchers will gather information from 125 patients to develop better algorithms …